The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation
Open accessAbstract
Purpose: To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). Methods: The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient advocate. The Panel was convened for the purpose of creating this guideline. We followed previously validated procedures for creating evidence-based guidelines. Working groups focused on initial presentation, ongoing management, and empiric antifungal therapy. Each working group developed key clinical questions, conducted systematic reviews of the published literature, and compiled evidence summaries. The Grades of Recommendation Assessment, Development, and Evaluation approach was used to generate summaries, and evidence was classified as high, moderate, low, or very low based on methodologic considerations. Results: Recommendations were made related to initial presentation (risk stratification, initial evaluation, and treatment), ongoing management (modification and cessation of empiric antibiotics), and empiric antifungal treatment (risk stratification, evaluation, and treatment) of pediatric FN. For each recommendation, the strength of the recommendation and level of evidence are presented. Conclusion: This guideline represents an evidence-based approach to FN specific to children with cancer. Although some recommendations are similar to adult-based guidelines, there are key distinctions in multiple areas. Implementation will require adaptation to the local context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citationGuidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Guidelines for the prevention of intravascular catheter-related infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.01.003 · Cited by 1,066
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 962
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
Brożek, J. L., Akl, E. A., Alonso‐Coello, P., Lang, D., Jaeschke, R., Williams, J. W., Phillips, B., Lelgemann, M., Lethaby, A., Bousquet, J., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.01973.x · Cited by 894
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Validation, updating and impact of clinical prediction rules: A review
Toll, D. B., Janssen, K. J. M., Vergouwe, Y., & Moons, K. G. M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.04.008 · Cited by 580
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Development of the AGREE II, part 1: performance, usefulness and areas for improvement
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Hanna, S. E., Makarski, J., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091714 · Cited by 499
Prentice, H. G., Hann, I. M., Herbrecht, R., Aoun, M., Kvaloy, S., Catovsky, D., Pinkerton, C. R., Schey, S. A., Jacobs, F., Oakhill, A., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2473063.x · Cited by 439
Management of febrile neutropenia: ESMO Clinical Practice Guidelines
de Naurois, J., Novitzky-Basso, I., Gill, M. J., Marti Marti, F., Cullen, M. H., & Roila, F. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq196 · Cited by 435
Connell, T. G., Rele, M., Cowley, D., Buttery, J. P., & Curtis, N. (2007) · Pediatrics · doi:10.1542/peds.2006-0440 · Cited by 401
Clinical Presentation of Infection in Granulocytopenic Patients
Sickles, E. A. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.135.5.715 · Cited by 385
Raad, I., Hanna, H. A., Alakech, B., Chatzinikolaou, I., Johnson, M. M., & Tarrand, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00007 · Cited by 354
Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases
Burgos, A., Zaoutis, T. E., Dvorak, C. C., Hoffman, J. A., Knapp, K. M., Nania, J. J., Prasad, P., & Steinbach, W. J. (2008) · Pediatrics · doi:10.1542/peds.2007-2117 · Cited by 343
Self-citationHeussel, C. P., Kauczor, H.-U., Heussel, G. E., Fischer, B., Begrich, M., Mildenberger, P., & Thelen, M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.796 · Cited by 305
White, M. H., Bowden, R. A., Sandler, E. S., Graham, M. L., Noskin, G. A., Wingard, J. R., Goldman, M., van Burik, J., McCabe, A., Lin, J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514672 · Cited by 303
Hann, I., Viscoli, C., Paesmans, M., Gaya, H., Glauser, M., & the International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4453255.x · Cited by 279
Paul, M., Soares-Weiser, K., & Leibovici, L. (2003) · BMJ · doi:10.1136/bmj.326.7399.1111 · Cited by 267
Maertens, J., Maertens, V., Theunissen, K., Meersseman, W., Meersseman, P., Meers, S., Verbeken, E., Verhoef, G., Van Eldere, J., & Lagrou, K. (2009) · Clinical Infectious Diseases · doi:10.1086/647935 · Cited by 247
Zaoutis, T. E., Heydon, K., Chu, J. H., Walsh, T. J., & Steinbach, W. J. (2006) · Pediatrics · doi:10.1542/peds.2005-1161 · Cited by 241
Self-citationDuration of empiric antibiotic therapy in granulocytopenic patients with cancer
Pizzo, P. A., Robichaud, K. J., Gill, F. A., Witebsky, F. G., Levine, A. S., Deisseroth, A. B., Glaubiger, D. L., MacLowry, J. D., Magrath, I. T., Poplack, D. G., et al. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90390-5 · Cited by 238
“Low-Risk” Prediction Rule for Pediatric Oncology Patients Presenting With Fever and Neutropenia
Klaassen, R. J., Goodman, T. R., Pham, B., & Doyle, J. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1012 · Cited by 234
Predicting the risk of bacteremia in childen with fever and neutropenia.
Rackoff, W. R., Gonin, R., Robinson, C., Kreissman, S. G., & Breitfeld, P. B. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.919 · Cited by 223
Principles and procedures for blood cultures : approved guideline
Clinical, & Wilson, M. L. (2007) · Clinical and Laboratory Standards Institute eBooks · Cited by 214
Hovi, L., Saarinen-Pihkala, U., Vettenranta, K., & Saxen, H. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702654 · Cited by 183
Frequency of Low-Level Bacteremia in Children from Birth to Fifteen Years of Age
Kellogg, J. A., Manzella, J. P., & Bankert, D. A. (2000) · Journal of Clinical Microbiology · doi:10.1128/.38.6.2181-2185.2000 · Cited by 179
Lucas, K. G., Brown, A. E., Armstrong, D., Chapman, D., & Heller, G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<791::aid-cncr27>3.0.co;2-v · Cited by 178
DesJardin, J. A., Falagas, M. E., Ruthazer, R., Griffith, J., Wawrose, D., Schenkein, D., Miller, K., & Snydman, D. R. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00002 · Cited by 177
Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation
Panackal, A. A., Li, H., Kontoyiannis, D. P., Mori, M., Perego, C. A., Boeckh, M., & Marr, K. A. (2010) · Clinical Infectious Diseases · doi:10.1086/652761 · Cited by 169
Effect of number of blood cultures and volume of blood on detection of bacteremia in children
Isaacman, D. J., Karasic, R. B., Reynolds, E. A., & Kost, S. I. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70388-8 · Cited by 168
Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., Engelhard, D., Marchetti, O., Akan, H., Skoutelis, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376637 · Cited by 168
Fungal Infections in Children With Cancer: A Prospective, Multicenter Surveillance Study
Castagnola, E., Cesaro, S., Giacchino, M., Livadiotti, S., Tucci, F., Zanazzo, G. A., Caselli, D., Caviglia, I., Parodi, S., Rondelli, R., et al. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000220256.69385.2e · Cited by 161
Self-citationAmmann, R. A., Bodmer, N., Hirt, A., Niggli, F. K., Nadal, D., Simon, A., Ozsahin, H., Kontny, U., Kühne, T., Popovic, M. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8988 · Cited by 160
Rosen, G. P., Nielsen, K., Glenn, S., Abelson, J., Deville, J., & Moore, T. B. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000155861.38641.ca · Cited by 158
Furno, P., Bucaneve, G., & Favero, A. D. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00241-4 · Cited by 150
Rohrlich, P., Sarfati, J., Mariani‐Kurkdjian, P., Duval, M., Carol, A., Saint‐Martin, C., Bingen, É., LATGE, J.-P., & VILMER, E. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00011 · Cited by 149
Viscoli, C., Machetti, M., Gazzola, P., Maria, A. D., Paola, D., Lint, M. T. V., Gualandi, F., Truini, M., & Bacigalupo, A. P. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1496-1499.2002 · Cited by 146
Groll, A. H., Kurz, M., Schneider, W., et al. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00496.x · Cited by 140
Self-citationInvasive fungal infections in pediatric oncology
Mor, M., Gilad, G., Kornreich, L., Fisher, S., Yaniv, I., & Levy, I. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23005 · Cited by 138
Improving the use of research evidence in guideline development: introduction
SURE, Oxman, A. D., Fretheim, A., & Schünemann, H. J. (2006) · Health Research Policy and Systems · doi:10.1186/1478-4505-4-12 · Cited by 136
Maertens, J. A., Madero, L., Reilly, A. F., Lehrnbecher, T., Groll, A. H., Jafri, H. S., Green, M., Nania, J. J., Bourque, M. R., Wise, B. A., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181da2171 · Cited by 136
Self-citationMullen, C. A., & Buchanan, G. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.12.1998 · Cited by 135
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
Vidal, L., Dor, I. B., Paul, M., Eliakim‐Raz, N., Pokroy, E., Soares‐Weiser, K., & Leibovici, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003992.pub3 · Cited by 120
Bash, R. O., Katz, J. A., Cash, J., & Buchanan, G. R. (1994) · Cancer · Cited by 118
Steinbach, W. J., Addison, R. M., McLaughlin, L., Gerrald, Q., Martin, P., Driscoll, T., Bentsen, C. G., Perfect, J. R., & Alexander, B. D. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3180616cbb · Cited by 112
Self-citationSmith, P. B., Benjamin, D. K., Alexander, B. D., Johnson, M. D., Finkelman, M., & Steinbach, W. J. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00025-07 · Cited by 104
Self-citationMori, R., Yonemoto, N., Fitzgerald, A., Tullus, K., Verrier‐Jones, K., & Lakhanpaul, M. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01644.x · Cited by 99
Early Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with Cancer
Aquino, V. M., Tkaczewski, I., & Buchanan, G. R. (1997) · Clinical Infectious Diseases · doi:10.1086/514512 · Cited by 98
Teuffel, O., Ethier, M. C., Alibhai, S. M. H., Beyene, J., & Sung, L. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq745 · Cited by 97
Self-citationSantolaya, M. E., Milena Villarroel, C., Avendaño, L. F., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/514500 · Cited by 92
Self-citationVardakas, K. Z., Samonis, G., Chrysanthopoulou, S. A., Bliziotis, I. A., & Falagas, M. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70164-x · Cited by 90
Paul, M., Yahav, D., Bivas, A., Fraser, A., & Leibovici, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005197.pub3 · Cited by 84
Risk Prediction in Pediatric Cancer Patients With Fever and Neutropenia
Hakim, H., Flynn, P. M., Srivastava, D. K., Knapp, K. M., Li, C., Okuma, J. O., & Gaur, A. H. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c3f6f0 · Cited by 81
Self-citationPhillips, R. S., Lehrnbecher, T., Alexander, S. W., & Sung, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038300 · Cited by 80
Self-citationNosocomial aspergillosis and building construction
Haiduven, D. (2008) · Medical Mycology · doi:10.1080/13693780802247694 · Cited by 79
CT of invasive pulmonary aspergillosis in children with cancer
Taccone, A., Occhi, M., Garaventa, A., Manfredini, L., & Viscoli, C. (1993) · Pediatric Radiology · doi:10.1007/bf02013825 · Cited by 78
El‐Mahallawy, H. A., Shaker, H. H., Helmy, H. A., Mostafa, T., & Abo-Sedah, A. R. (2006) · Medical Mycology · doi:10.1080/13693780600939955 · Cited by 78
Griffin, T. C., & Buchanan, G. R. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82536-3 · Cited by 77
Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
Joshi, J. H., Schimpff, S. C., Tenney, J. H., et al. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90664-8 · Cited by 74
Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
Hayden, R. T., Pounds, S. B., Knapp, K. M., Petraitienė, R., Schaufele, R. L., Sein, T., & Walsh, T. J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817197ab · Cited by 74
Desai, R., Ross, L. A., & Hoffman, J. A. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818f0934 · Cited by 71
Hovi, L., Saxén, H., Saarinen‐Pihkala, U. M., Vettenranta, K. K., Meri, T., & Richardson, M. D. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20717 · Cited by 67
Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
Marchetti, O., Cordonnier, C., & Calandra, T. (2007) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2007.06.005 · Cited by 64
Barriga, F., Varas, M., Potı́n, M., Sapunar, F. J., Rojo, H., Martinez, A., Verónica Capdeville, M., Becker, A., & Vial, P. (1997) · Medical and Pediatric Oncology · Cited by 61
Cost-effectiveness of Outpatient Management for Febrile Neutropenia in Children With Cancer
Teuffel, O., Amir, E., Alibhai, S. M. H., Beyene, J., & Sung, L. (2011) · PEDIATRICS · doi:10.1542/peds.2010-0734 · Cited by 60
Self-citationPhillips, B., Wade, R., Stewart, L. A., & Sutton, A. J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.024 · Cited by 59
Risk Factors Associated With Invasive Fungal Disease in Children With Cancer and Febrile Neutropenia
Milena Villarroel, C., Avilés, C. L., Silva, P., Guzmán, A. M., Helena Poggi, M., Alvarez, A., Becker, A., O’Ryan, M., Salgado, C., Topelberg, S., V, et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181e7db7f · Cited by 58
Self-citationCastagnola, E., Furfaro, E., Caviglia, I., Licciardello, M., Faraci, M., Fioredda, F., Tomà, P., Bandettini, R., Machetti, M., & Viscoli, C. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03065.x · Cited by 56
Self-citationMacher, E., Dubos, F., Garnier, N., Delebarre, M., de Berranger, E., Thébaud, E., Mazingue, F., Leblond, P., & Martinot, A. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22586 · Cited by 56
Manji, A., Beyene, J., Dupuis, L. L., Phillips, B., Lehrnbecher, T., & Sung, L. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1425-8 · Cited by 53
Self-citationDommett, R. M., Geary, J., Freeman, S., Hartley, J. C., Sharland, M., Davidson, A., Tulloh, R. M. R., Taj, M., Stoneham, S. J., & Chisholm, J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.003 · Cited by 53
Hodgson‐Viden, H., Grundy, P. E., & Robinson, J. L. (2005) · BMC Pediatrics · doi:10.1186/1471-2431-5-10 · Cited by 50
Armenian, S. H., Nash, K. A., Kapoor, N. R., Franklin, J. L., Gaynon, P. S., Ross, L. A., & Hoffman, J. A. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181b83e77 · Cited by 50
High Levels of β- d -Glucan in Immunocompromised Children with Proven Invasive Fungal Disease
Mularoni, A., Furfaro, E., Faraci, M., Franceschi, A., Mezzano, P., Bandettini, R., Viscoli, C., & Castagnola, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00038-10 · Cited by 50
Self-citationInfection Risk Factors in Febrile, Neutropenic Children and Adolescents
Jones, G. R., Konsler, G. K., Dunaway, R. P., et al. (1996) · Pediatric Hematology and Oncology · doi:10.3109/08880019609030820 · Cited by 47
Lehrnbecher, T., Stanescu, A., & Kühl, J. (2002) · Infection · doi:10.1007/s15010-002-2094-1 · Cited by 46
Self-citationComputed tomography in the evaluation of febrile neutropenic pediatric oncology patients
ARCHIBALD, S., Park, J., Geyer, J. R., & HAWKINS, D. S. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200101000-00002 · Cited by 46
PERIPHERAL VS. CENTRAL BLOOD CULTURES IN PATIENTS ADMITTED TO A PEDIATRIC ONCOLOGY WARD
Adamkiewicz, T. V., Lorenzana, A., Doyle, J., et al. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199906000-00018 · Cited by 41
Speyer, É., Herbinet, A., Vuillemin, A., Chastagner, P. B., & Briançon, S. (2009) · Child Care Health and Development · doi:10.1111/j.1365-2214.2009.00972.x · Cited by 40
Cornelissen, J. J., Rozenberg-Arska, M., & Dekker, A. W. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1300 · Cited by 39
de Marie, S., van den Broek, P. J., Willemze, R., et al. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01992162 · Cited by 30
Flynn, P. M., Shenep, J. L., Crawford, R., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.964 · Cited by 30
Sörensen, J., Becker, M., Porto, L., et al. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01300.x · Cited by 27
[Value of plasma beta-Glucan in early diagnosis of invasive fungal infection in children].
Zhao, L., Tang, J., Wang, Y., Zhou, Y.-F., Chen, J., Li, B.-R., & Xue, H.-L. (2009) · PubMed · Cited by 27
Cerebral aspergillosis in an infant with corticosteroid-resistant nephrotic syndrome
Roilides, E., Pavlidou, E., Papadopoulos, F., Panteliadis, C. P., Farmaki, E., Tamiolaki, M., & Sotiriou, J. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1113-5 · Cited by 26
Agrawal, A. K., Saini, N. Y., Gildengorin, G. L., & Feusner, J. H. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22974 · Cited by 24
Phillips, B., Wade, R., Westwood, M. E., et al. (2011) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2011.02211.x · Cited by 15
Cited by
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Lehrnbecher, T., Robinson, P., Fisher, B., Alexander, S., Ammann, R. A., Beauchemin, M., Carlesse, F., Groll, A. H., Haeusler, G. M., Santolaya, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.7017 · Cited by 449
Self-citationGroll, A. H., Castagnola, E., Cesaro, S., Dalle, J.-H., Engelhard, D., Hope, W., Roilides, E., Styczynski, J., Warris, A., & Lehrnbecher, T. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70017-8 · Cited by 407
Self-citationCollaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
Zwaan, C. M., Kolb, E. A., Reinhardt, D., Abrahamsson, J., Adachi, S., Aplenc, R., De Bont, E. S. J. M., De Moerloose, B., Dworzak, M., Gibson, B. E. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.8289 · Cited by 383
Self-citationUse of 1,3-β-D-glucan in invasive fungal diseases in hematology patients
Giacobbe, D. R., Del Bono, V., Viscoli, C., & Mikulska, M. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1401467 · Cited by 27
Metadata
- Authors
- Lehrnbecher, T., Phillips, R., Alexander, S., Alvaro, F., Carlesse, F., Fisher, B., Hakim, H., Santolaya, M., Castagnola, E., Davis, B. L., Dupuis, L. L., Gibson, F., Groll, A. H., Gaur, A., Gupta, A., Kebudi, R., Petrilli, S., Steinbach, W. J., Villarroel, M., Zaoutis, T., & Sung, L.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-12-10
- Volume
- 30
- Issue
- 35
- Pages
- 4427-4438
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2115832986
- Cited by
- 353
- References
- 91
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.